Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaccinia Vaccination (ACAM2000®) of Plasma Donors for the Production of Vaccinia Immune Globulin Intravenous (VIGIV)

NCT02443623 is registered in ClinicalTrials.gov with Emergent BioSolutions as lead sponsor.

NCT NCT02443623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02443623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaccinia Vaccination (ACAM2000®) of Plasma Donors for the Production of Vaccinia Immune Globulin Intravenous (VIGIV)
Lead sponsor
Emergent BioSolutions
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2015
Completion date
August 31, 2021
Enrollment
3,032 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smallpox vaccine adverse reaction